Back to Search Start Over

P1.03-02 Combinationof Anlotinib and Tislelizumab for Lung Adenocarcinoma: Effects on Metabolic and Flora Microenvironment.

Authors :
Nie, Y.
Yang, Z.
Yao, G.
Xu, X.
Zhao, Y.
Yin, K.
Zhang, W.
Li, Q.
zhou, F.
Source :
Journal of Thoracic Oncology; 2023 Supplement, Vol. 18 Issue 11, pS191-S192, 2p
Publication Year :
2023

Details

Language :
English
ISSN :
15560864
Volume :
18
Issue :
11
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
173322893
Full Text :
https://doi.org/10.1016/j.jtho.2023.09.299